Caring About Cancer Patients
"Memoirs of Cancer" Book Now Available   - Caring About Cancer Patients
RSS Follow

Delivered by FeedBurner


Recent Posts

PANCREAS CANCER NEWS
Cervical Cancer is an International Issue
Cancer Death Rates Declining But Disparity for African Americans Still Exist
Danstock: 4 Bands 2 Raise $ 4 Cancer Research
Is a Clinical Trial Right for You?

Most Popular Posts

Sugar considered a culprit in cancer cases
Secondary Liver Cancer
The Virus HLTV-1 and Cancer
Herbs That Can Help Cancer Patients-PERIWINKLE
Antipsychotic Drug Controls "Breakthrough" Nausea and Vomiting after Chemotherapy

Categories

African American
Anal Cancer
Bladder Cancer
Brain Cancer
Breast Cancer
Breast Cancer Awareness Month
Cancer and Fertility
CANCER AND OBESITY
Cancer and Stem Cells
Cancer Care/Self-Help
CANCER EVENTS
Cancer Facts/Statistics
Cancer Information/Updates
Cancer Loss
Cancer Memories
Cancer Prevention
cancer research
Causes of cancer
Cervical cancer
Chemotherapy
Children and cancer
Clinical Trials for Cancer
colon cancer
COLORECTAL CANCER
Exciting
Head and Neck Cancer
Health Care Disparities
Help for Cancer Patient Caregivers
JOB TRAINING
Liver Cancer
LUNG CANCER
Melanoma
Metastatic Cancer
Multicultural
Multiple Myeloma Cancer
New Cancer Info.
ovarian cancer
Pancreatic Cancer
Pancreatic Cancer Awareness Month
PROSTATE CANCER
Stomach Cancer
TRIPLE NEGATIVE BREAST CANCERS

Archives

April 2013
February 2013
January 2013
December 2012
November 2012
October 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011

powered by

Caring About Cancer Patients

Children and cancer

Some Children with Hodgkin Lymphoma May Not Need Radiation Therapy

Children with Hodgkin lymphoma who have favorable clinical features and who respond early to chemotherapy may not need treatment with radiation. The finding, reported in the June 27JAMA, is from a clinical trial of 88 patients with low-risk disease.

Patients who had an early complete response to the chemotherapy regimen used in the trial and were not treated with radiation therapy (as stipulated in the study protocol) had 5-year survival rates similar to those of children who did not have the same response to chemotherapy and therefore required radiation.

Lung Cancer Drug Shows Promise against Several Childhood Cancers

Preliminary results from a phase I clinical trial suggest that the targeted drug crizotinib (Xalkori) may be effective in children with cancer whose tumors harbor genetic alterations in the ALK gene. In some children, the drug caused all signs of the disease to disappear (complete response). Crizotinib is already approved by the Food and Drug Administration to treat patients with lung cancer whose tumors have ALK mutations.
The findings were presented at a press briefing on May 16 in advance of the American Society of Clinical Oncology (ASCO) annual meeting .

For Many Young Cancer Survivors, Late Effects Pose Lasting Problems


"Last summer I was diagnosed with bilateral Avascular Necrosis in my hips from all of the prednisone I received throughout the years [of chemotherapy]. In the fall I had core decompression on my left hip and it was pretty useless in resolving my chronic bone pain.… Because of my age (21) my orthopedic surgeon does not want to perform hip replacement surgery and I feel like I'm sort of just stuck with the pain without any resolution."

—Post on stupidcancer.com forumCataracts, hearing loss, chronic pain, amputation,

Uncovering the Biology of Cancers in Adolescents and Young Adults

If you are interested in information on adolescents and cancer read on:

The first scientific journal dedicated to cancers in adolescents and young adults (AYAs) published its first issue in March, marking a milestone for the emerging field of AYA oncology. But as experts noted in a roundtable discussion in the issue, the field faces many challenges, particularly when it comes to understanding the biology of these diseases.At one point in the conversation, Dr. Archie Bleyer of the St. Charles Regional Cancer Center in Bend, OR, shared a concern about the state of the science.